mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.09 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.09 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.09 |
mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.1 |
mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.1 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |